| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | delta14-sterol reductase activity | 3.35e-05 | 2 | 116 | 2 | GO:0050613 | |
| GeneOntologyMolecularFunction | vinculin binding | 5.24e-05 | 13 | 116 | 3 | GO:0017166 | |
| GeneOntologyMolecularFunction | anandamide 8,9 epoxidase activity | 1.99e-04 | 4 | 116 | 2 | GO:0062187 | |
| GeneOntologyMolecularFunction | anandamide 11,12 epoxidase activity | 1.99e-04 | 4 | 116 | 2 | GO:0062188 | |
| GeneOntologyMolecularFunction | steroid 21-monooxygenase activity | 1.99e-04 | 4 | 116 | 2 | GO:0004509 | |
| GeneOntologyMolecularFunction | progesterone 21-hydroxylase activity | 1.99e-04 | 4 | 116 | 2 | GO:0106309 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | EML4 SPTA1 SPTB OBSCN DAG1 EML3 CYFIP1 CCDC88A DST NF1 NISCH MACF1 DMD UTRN UNC13A MYO16 TBCEL | 2.03e-04 | 1099 | 116 | 17 | GO:0008092 |
| GeneOntologyMolecularFunction | H3K27me3 modified histone binding | 3.31e-04 | 5 | 116 | 2 | GO:0061628 | |
| GeneOntologyMolecularFunction | actin binding | 4.85e-04 | 479 | 116 | 10 | GO:0003779 | |
| GeneOntologyMolecularFunction | anandamide 14,15 epoxidase activity | 4.94e-04 | 6 | 116 | 2 | GO:0062189 | |
| GeneOntologyMolecularFunction | anandamide epoxidase activity | 4.94e-04 | 6 | 116 | 2 | GO:0062186 | |
| GeneOntologyMolecularFunction | tubulin binding | 8.87e-04 | 428 | 116 | 9 | GO:0015631 | |
| GeneOntologyMolecularFunction | TBP-class protein binding | 9.18e-04 | 33 | 116 | 3 | GO:0017025 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor | 1.00e-03 | 34 | 116 | 3 | GO:0016628 | |
| GeneOntologyMolecularFunction | RNA polymerase I general transcription initiation factor activity | 1.17e-03 | 9 | 116 | 2 | GO:0001181 | |
| GeneOntologyCellularComponent | dystrophin-associated glycoprotein complex | 1.82e-04 | 20 | 117 | 3 | GO:0016010 | |
| GeneOntologyCellularComponent | zeta DNA polymerase complex | 1.85e-04 | 4 | 117 | 2 | GO:0016035 | |
| GeneOntologyCellularComponent | excitatory synapse | 3.40e-04 | 107 | 117 | 5 | GO:0060076 | |
| GeneOntologyCellularComponent | glycoprotein complex | 3.59e-04 | 25 | 117 | 3 | GO:0090665 | |
| MousePheno | hepatic necrosis | 1.30e-05 | 79 | 92 | 6 | MP:0001654 | |
| MousePheno | cerebral infarct | 4.28e-05 | 2 | 92 | 2 | MP:0021003 | |
| Domain | Spectrin | 3.77e-09 | 23 | 112 | 6 | PF00435 | |
| Domain | Spectrin_repeat | 1.72e-08 | 29 | 112 | 6 | IPR002017 | |
| Domain | SPEC | 3.24e-08 | 32 | 112 | 6 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 3.24e-08 | 32 | 112 | 6 | IPR018159 | |
| Domain | ACTININ_2 | 2.19e-07 | 23 | 112 | 5 | PS00020 | |
| Domain | ACTININ_1 | 2.19e-07 | 23 | 112 | 5 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 2.19e-07 | 23 | 112 | 5 | IPR001589 | |
| Domain | ARM-like | 5.23e-06 | 270 | 112 | 10 | IPR011989 | |
| Domain | TFIID_sub1_DUF3591 | 3.56e-05 | 2 | 112 | 2 | IPR022591 | |
| Domain | TBP-binding | 3.56e-05 | 2 | 112 | 2 | PF09247 | |
| Domain | DUF3591 | 3.56e-05 | 2 | 112 | 2 | PF12157 | |
| Domain | Dystrophin | 3.56e-05 | 2 | 112 | 2 | IPR016344 | |
| Domain | TAF_II_230-bd | 3.56e-05 | 2 | 112 | 2 | IPR009067 | |
| Domain | - | 3.56e-05 | 2 | 112 | 2 | 1.10.1100.10 | |
| Domain | TAF1_animal | 3.56e-05 | 2 | 112 | 2 | IPR011177 | |
| Domain | CH | 4.40e-05 | 65 | 112 | 5 | SM00033 | |
| Domain | - | 5.79e-05 | 222 | 112 | 8 | 1.25.10.10 | |
| Domain | CH | 6.29e-05 | 70 | 112 | 5 | PF00307 | |
| Domain | - | 6.73e-05 | 71 | 112 | 5 | 1.10.418.10 | |
| Domain | CH | 7.70e-05 | 73 | 112 | 5 | PS50021 | |
| Domain | CH-domain | 8.76e-05 | 75 | 112 | 5 | IPR001715 | |
| Domain | Sterol_reductase_CS | 1.07e-04 | 3 | 112 | 2 | IPR018083 | |
| Domain | ERG4_ERG24 | 1.07e-04 | 3 | 112 | 2 | PF01222 | |
| Domain | Ergosterol_biosynth_ERG4_ERG24 | 1.07e-04 | 3 | 112 | 2 | IPR001171 | |
| Domain | STEROL_REDUCT_2 | 1.07e-04 | 3 | 112 | 2 | PS01018 | |
| Domain | STEROL_REDUCT_1 | 1.07e-04 | 3 | 112 | 2 | PS01017 | |
| Domain | C2 | 1.38e-04 | 131 | 112 | 6 | PF00168 | |
| Domain | C2 | 1.77e-04 | 137 | 112 | 6 | SM00239 | |
| Domain | - | 1.78e-04 | 261 | 112 | 8 | 1.10.238.10 | |
| Domain | WW | 1.79e-04 | 47 | 112 | 4 | PF00397 | |
| Domain | WW | 1.95e-04 | 48 | 112 | 4 | SM00456 | |
| Domain | ARM-type_fold | 2.05e-04 | 339 | 112 | 9 | IPR016024 | |
| Domain | IZUMO | 2.12e-04 | 4 | 112 | 2 | IPR029389 | |
| Domain | IZUMO | 2.12e-04 | 4 | 112 | 2 | PF15005 | |
| Domain | C2 | 2.15e-04 | 142 | 112 | 6 | PS50004 | |
| Domain | WW_DOMAIN_1 | 2.46e-04 | 51 | 112 | 4 | PS01159 | |
| Domain | WW_DOMAIN_2 | 2.46e-04 | 51 | 112 | 4 | PS50020 | |
| Domain | WW_dom | 2.66e-04 | 52 | 112 | 4 | IPR001202 | |
| Domain | - | 2.68e-04 | 148 | 112 | 6 | 2.60.40.150 | |
| Domain | EF-hand-dom_pair | 3.37e-04 | 287 | 112 | 8 | IPR011992 | |
| Domain | Munc13_dom-2 | 3.52e-04 | 5 | 112 | 2 | IPR014772 | |
| Domain | MHD2 | 3.52e-04 | 5 | 112 | 2 | PS51259 | |
| Domain | Munc13_subgr_dom-2 | 3.52e-04 | 5 | 112 | 2 | IPR019558 | |
| Domain | Membr_traf_MHD | 3.52e-04 | 5 | 112 | 2 | PF10540 | |
| Domain | C2_dom | 4.65e-04 | 164 | 112 | 6 | IPR000008 | |
| Domain | - | 5.26e-04 | 6 | 112 | 2 | 3.90.1290.10 | |
| Domain | GAR | 5.26e-04 | 6 | 112 | 2 | PS51460 | |
| Domain | HELP | 5.26e-04 | 6 | 112 | 2 | PF03451 | |
| Domain | GAS2 | 5.26e-04 | 6 | 112 | 2 | PF02187 | |
| Domain | EF-hand_dom_typ1 | 5.26e-04 | 6 | 112 | 2 | IPR015153 | |
| Domain | EF-hand_dom_typ2 | 5.26e-04 | 6 | 112 | 2 | IPR015154 | |
| Domain | - | 5.26e-04 | 6 | 112 | 2 | 3.30.920.20 | |
| Domain | HELP | 5.26e-04 | 6 | 112 | 2 | IPR005108 | |
| Domain | EF-hand_2 | 5.26e-04 | 6 | 112 | 2 | PF09068 | |
| Domain | EF-hand_3 | 5.26e-04 | 6 | 112 | 2 | PF09069 | |
| Domain | GAS_dom | 5.26e-04 | 6 | 112 | 2 | IPR003108 | |
| Domain | GAS2 | 5.26e-04 | 6 | 112 | 2 | SM00243 | |
| Domain | Munc13_1 | 7.34e-04 | 7 | 112 | 2 | IPR014770 | |
| Domain | MHD1 | 7.34e-04 | 7 | 112 | 2 | PS51258 | |
| Domain | Plectin | 7.34e-04 | 7 | 112 | 2 | PF00681 | |
| Domain | DUF1041 | 7.34e-04 | 7 | 112 | 2 | PF06292 | |
| Domain | Plectin_repeat | 7.34e-04 | 7 | 112 | 2 | IPR001101 | |
| Domain | CAPS_dom | 7.34e-04 | 7 | 112 | 2 | IPR010439 | |
| Domain | PLEC | 7.34e-04 | 7 | 112 | 2 | SM00250 | |
| Domain | HEAT_REPEAT | 8.29e-04 | 70 | 112 | 4 | PS50077 | |
| Domain | CRAL_TRIO_2 | 2.26e-03 | 12 | 112 | 2 | PF13716 | |
| Domain | EFh | 2.64e-03 | 158 | 112 | 5 | SM00054 | |
| Domain | ER_TARGET | 2.81e-03 | 47 | 112 | 3 | PS00014 | |
| Domain | HEAT | 2.98e-03 | 48 | 112 | 3 | PF02985 | |
| Domain | EF-hand_like | 3.56e-03 | 15 | 112 | 2 | PF09279 | |
| Domain | PI-PLC-Y | 3.56e-03 | 15 | 112 | 2 | PF00387 | |
| Domain | PLCYc | 3.56e-03 | 15 | 112 | 2 | SM00149 | |
| Domain | PLipase_C_Pinositol-sp_Y | 3.56e-03 | 15 | 112 | 2 | IPR001711 | |
| Domain | PIPLC_Y_DOMAIN | 3.56e-03 | 15 | 112 | 2 | PS50008 | |
| Domain | PI-PLC_fam | 3.56e-03 | 15 | 112 | 2 | IPR001192 | |
| Domain | PLC_EF-hand-like | 3.56e-03 | 15 | 112 | 2 | IPR015359 | |
| Domain | UBIQUITIN_2 | 4.17e-03 | 54 | 112 | 3 | PS50053 | |
| Domain | HEAT | 5.10e-03 | 58 | 112 | 3 | IPR000357 | |
| Domain | Ubiquitin_dom | 5.10e-03 | 58 | 112 | 3 | IPR000626 | |
| Domain | ZF_ZZ_2 | 5.12e-03 | 18 | 112 | 2 | PS50135 | |
| Domain | PI-PLC-X | 5.12e-03 | 18 | 112 | 2 | PF00388 | |
| Domain | ZF_ZZ_1 | 5.12e-03 | 18 | 112 | 2 | PS01357 | |
| Domain | PLCXc | 5.12e-03 | 18 | 112 | 2 | SM00148 | |
| Domain | ZZ | 5.12e-03 | 18 | 112 | 2 | PF00569 | |
| Domain | Znf_ZZ | 5.70e-03 | 19 | 112 | 2 | IPR000433 | |
| Domain | PIPLC_X_DOMAIN | 5.70e-03 | 19 | 112 | 2 | PS50007 | |
| Domain | PLipase_C_PInositol-sp_X_dom | 5.70e-03 | 19 | 112 | 2 | IPR000909 | |
| Domain | ZnF_ZZ | 5.70e-03 | 19 | 112 | 2 | SM00291 | |
| Pubmed | SART3 ARHGEF28 EML4 DOCK10 BTAF1 COLGALT1 RSPRY1 CUL5 PARP4 CCDC88A DST RPAP1 SUPV3L1 WDCP NISCH TCF25 UGGT2 TIMELESS ZBED1 | 7.03e-13 | 650 | 117 | 19 | 38777146 | |
| Pubmed | N-terminal α Dystroglycan (αDG-N): A Potential Serum Biomarker for Duchenne Muscular Dystrophy. | 3.71e-08 | 3 | 117 | 3 | 27854211 | |
| Pubmed | 3.71e-08 | 3 | 117 | 3 | 25324540 | ||
| Pubmed | 3.71e-08 | 3 | 117 | 3 | 25082828 | ||
| Pubmed | 3.71e-08 | 3 | 117 | 3 | 8589441 | ||
| Pubmed | 1.48e-07 | 4 | 117 | 3 | 8954775 | ||
| Pubmed | 1.48e-07 | 4 | 117 | 3 | 17389230 | ||
| Pubmed | SART3 PPFIA4 SPTA1 SPTB FKBP9 RTN3 CUL5 CYFIP1 DST NF1 SACS HECW2 NISCH MACF1 HADHA DMD AKR1B1 UTRN UNC13A | 3.12e-07 | 1431 | 117 | 19 | 37142655 | |
| Pubmed | 3.69e-07 | 5 | 117 | 3 | 22493004 | ||
| Pubmed | 3.69e-07 | 5 | 117 | 3 | 11430802 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SART3 EML4 POLD2 DOCK10 CHD4 HEATR1 LBR COLGALT1 URB1 CYFIP1 DST NF1 SUPV3L1 MACF1 HADHA GCN1 UTRN MED12 | 6.43e-07 | 1353 | 117 | 18 | 29467282 |
| Pubmed | Expression of the dystrophin-related protein 2 (Drp2) transcript in the mouse. | 7.37e-07 | 6 | 117 | 3 | 9245586 | |
| Pubmed | 7.37e-07 | 6 | 117 | 3 | 10767429 | ||
| Pubmed | Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle. | 1.29e-06 | 7 | 117 | 3 | 1461282 | |
| Pubmed | 2.05e-06 | 8 | 117 | 3 | 18586242 | ||
| Pubmed | Genetic mapping in the region of the mouse X-inactivation center. | 2.05e-06 | 8 | 117 | 3 | 1974879 | |
| Pubmed | SART3 CHD4 HEATR1 URB1 DST NF1 MACF1 WDR12 HADHA GCN1 UTRN MED12 | 2.21e-06 | 653 | 117 | 12 | 22586326 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | DAG1 RTN3 BTAF1 HEATR1 LBR URB1 RPAP1 ATAD1 NISCH TCF25 UGGT2 TIMELESS HADHA GCN1 | 3.61e-06 | 942 | 117 | 14 | 31073040 |
| Pubmed | 4.38e-06 | 10 | 117 | 3 | 2055107 | ||
| Pubmed | 4.38e-06 | 10 | 117 | 3 | 14627610 | ||
| Pubmed | 5.65e-06 | 131 | 117 | 6 | 28031328 | ||
| Pubmed | 5.81e-06 | 285 | 117 | 8 | 32838362 | ||
| Pubmed | Characterization of a murine gene expressed from the inactive X chromosome. | 6.00e-06 | 11 | 117 | 3 | 2034278 | |
| Pubmed | PRUNE2 SLC4A8 ARHGEF28 PPFIA4 RSPRY1 PARP4 FAT2 SACS MACF1 MED12 | 6.89e-06 | 493 | 117 | 10 | 15368895 | |
| Pubmed | ELMOD2 EML4 DOCK10 CHD4 HEATR1 LBR COLGALT1 ITGAX PARP4 NF1 ATAD1 NISCH GCN1 MED12 RUSF1 | 9.17e-06 | 1168 | 117 | 15 | 19946888 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | SART3 EML4 XPO4 ZYG11B HEATR1 RSPRY1 CYFIP1 CCDC88A NF1 ATAD1 WDCP NISCH UGGT2 GCN1 MUC5AC RUSF1 | 9.35e-06 | 1321 | 117 | 16 | 27173435 |
| Pubmed | Rps4 maps near the inactivation center on the mouse X chromosome. | 1.04e-05 | 13 | 117 | 3 | 1740345 | |
| Pubmed | 1.04e-05 | 13 | 117 | 3 | 8012115 | ||
| Pubmed | XIST and the mapping of the X chromosome inactivation centre. | 1.04e-05 | 13 | 117 | 3 | 1772416 | |
| Pubmed | 1.04e-05 | 13 | 117 | 3 | 7805729 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 10525423 | ||
| Pubmed | In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice. | 1.12e-05 | 2 | 117 | 2 | 28790199 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 28572004 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 16784888 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 25859846 | ||
| Pubmed | Structure of a WW domain containing fragment of dystrophin in complex with beta-dystroglycan. | 1.12e-05 | 2 | 117 | 2 | 10932245 | |
| Pubmed | G-utrophin, the autosomal homologue of dystrophin Dp116, is expressed in sensory ganglia and brain. | 1.12e-05 | 2 | 117 | 2 | 7731967 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 16710609 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 17403717 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 30672725 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 1391962 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 7962191 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 20142806 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 8021701 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 26974331 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 11002341 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 28453658 | ||
| Pubmed | A quantitative study of bioenergetics in skeletal muscle lacking utrophin and dystrophin. | 1.12e-05 | 2 | 117 | 2 | 11801396 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 7987307 | ||
| Pubmed | Comparative analysis of the human dystrophin and utrophin gene structures. | 1.12e-05 | 2 | 117 | 2 | 11861579 | |
| Pubmed | Distinct mechanical properties in homologous spectrin-like repeats of utrophin. | 1.12e-05 | 2 | 117 | 2 | 30914715 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 22284942 | ||
| Pubmed | Haploinsufficiency of utrophin gene worsens skeletal muscle inflammation and fibrosis in mdx mice. | 1.12e-05 | 2 | 117 | 2 | 17889902 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 25808902 | ||
| Pubmed | Chaperone activity and prodan binding at the self-associating domain of erythroid spectrin. | 1.12e-05 | 2 | 117 | 2 | 15492010 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 8102379 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 11207030 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 35557546 | ||
| Pubmed | Characterization of the Ang/Tie2 Signaling Pathway in the Diaphragm Muscle of DMD Mice. | 1.12e-05 | 2 | 117 | 2 | 37626761 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 9414314 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 15565469 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 26516677 | ||
| Pubmed | Assessment of cardiac function in three mouse dystrophinopathies by magnetic resonance imaging. | 1.12e-05 | 2 | 117 | 2 | 22209498 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 9005995 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 7104494 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 6215583 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 37108685 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 10694796 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 38804708 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 24337461 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 11297940 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 3580577 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 7883966 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 22388933 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 25642938 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 17360660 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 15703201 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 25941878 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 22842574 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 7894483 | ||
| Pubmed | Duchenne muscular dystrophy and the neuromuscular junction: the utrophin link. | 1.12e-05 | 2 | 117 | 2 | 9297964 | |
| Pubmed | Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. | 1.12e-05 | 2 | 117 | 2 | 3123997 | |
| Pubmed | The WW domain of dystrophin requires EF-hands region to interact with beta-dystroglycan. | 1.12e-05 | 2 | 117 | 2 | 10355629 | |
| Pubmed | SERCA1 overexpression minimizes skeletal muscle damage in dystrophic mouse models. | 1.12e-05 | 2 | 117 | 2 | 25652448 | |
| Pubmed | Utrophin Compensates dystrophin Loss during Mouse Spermatogenesis. | 1.12e-05 | 2 | 117 | 2 | 28785010 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 16307000 | ||
| Pubmed | Dystroglycan Mediates Clustering of Essential GABAergic Components in Cerebellar Purkinje Cells. | 1.12e-05 | 2 | 117 | 2 | 32982691 | |
| Pubmed | Spectrin Cosenza: a novel beta chain variant associated with Sp alphaI/74 hereditary elliptocytosis. | 1.12e-05 | 2 | 117 | 2 | 9163587 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 21949353 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 23097179 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 15501597 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 27571988 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 11257121 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 8018926 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 34403156 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 18973234 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 27881412 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 16023353 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 20625423 | ||
| Pubmed | Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle. | 1.12e-05 | 2 | 117 | 2 | 29065908 | |
| Cytoband | 11q22.3 | 1.98e-04 | 44 | 117 | 3 | 11q22.3 | |
| GeneFamily | UNC13 homologs | 1.12e-04 | 4 | 79 | 2 | 836 | |
| GeneFamily | IZUMO family | 1.12e-04 | 4 | 79 | 2 | 56 | |
| GeneFamily | EF-hand domain containing|Spectrins | 3.90e-04 | 7 | 79 | 2 | 1113 | |
| GeneFamily | EF-hand domain containing|Plakins | 5.19e-04 | 8 | 79 | 2 | 939 | |
| GeneFamily | EF-hand domain containing | 2.71e-03 | 219 | 79 | 5 | 863 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 2.76e-03 | 18 | 79 | 2 | 91 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 3.07e-03 | 19 | 79 | 2 | 832 | |
| GeneFamily | DNA polymerases | 4.49e-03 | 23 | 79 | 2 | 535 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.79e-07 | 184 | 117 | 7 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.80e-07 | 199 | 117 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.17e-06 | 180 | 117 | 6 | 6ac62bf1251978c8c12e715f7b73144fca619794 | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|World / Disease state, Lineage and Cell class | 9.55e-06 | 185 | 117 | 6 | 85cb81759589a26d83676cffbf2bc37399683c10 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.05e-05 | 188 | 117 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.05e-05 | 188 | 117 | 6 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|Control / Disease state, Lineage and Cell class | 1.08e-05 | 189 | 117 | 6 | 937e876122bc4b94372a4104e9c1a9068c232018 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.08e-05 | 189 | 117 | 6 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | IPF-Myeloid-Macrophage_Alveolar|Myeloid / Disease state, Lineage and Cell class | 1.11e-05 | 190 | 117 | 6 | 2592765016f291565697265800a232b2edef3792 | |
| ToppCell | facs-GAT-Fat-3m|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-05 | 190 | 117 | 6 | 1d92be1b41cff59e834a9d28868f554bd1f3e471 | |
| ToppCell | COPD-Myeloid-Macrophage_Alveolar|Myeloid / Disease state, Lineage and Cell class | 1.11e-05 | 190 | 117 | 6 | 9fc763d65470ba8858b973689c4d4358faab7dd3 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.14e-05 | 191 | 117 | 6 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|Myeloid / Disease state, Lineage and Cell class | 1.14e-05 | 191 | 117 | 6 | a7bb8aba9c59c037d995a77928cc7b4d5cbb82b9 | |
| ToppCell | COVID-19-lung-Macrophage_PPARGhi_CD5Lhi|lung / Disease (COVID-19 only), tissue and cell type | 1.14e-05 | 191 | 117 | 6 | dab953682b8c9ed680a799161f837f792a7e4f33 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D175|Adult / Lineage, Cell type, age group and donor | 1.18e-05 | 192 | 117 | 6 | 733491e932350e3c216a626cc49c3cd3fe970a82 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.21e-05 | 193 | 117 | 6 | 315840bc48899f3a36d57b19197509de19716e3d | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.29e-05 | 195 | 117 | 6 | 9d649ac7d2af313481069c95349efc0c68449e2b | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 195 | 117 | 6 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 195 | 117 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)|Adult / Lineage, Cell type, age group and donor | 1.29e-05 | 195 | 117 | 6 | 55e25f702af19146a161861cfd15f40bbda1dc35 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 195 | 117 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | facs-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 196 | 117 | 6 | 44f5b1b474399c9316729155f2ea95a82ca66e30 | |
| ToppCell | facs-Bladder-nan-3m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 196 | 117 | 6 | c0e90d964baa2eb4fbd18a52379ccec5d3bf59a8 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-05 | 198 | 117 | 6 | e125eb8aa57c172e5518874da1bd25998292f5e2 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-05 | 198 | 117 | 6 | 0baeb8e2c199ff10bb5c829c523546af3c9227c1 | |
| ToppCell | ASK440|World / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.40e-05 | 198 | 117 | 6 | f3ed6efd521c691debae32a803972bed5d069332 | |
| ToppCell | COVID-19-lung|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.44e-05 | 199 | 117 | 6 | 155b03b859157013e9142e9248551369127d9204 | |
| ToppCell | Parenchyma_Control_(B.)-Immune-TX-TRAM-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.49e-05 | 200 | 117 | 6 | 7c56935446f10d202eafa1f9ee7cb0aae4c2607e | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.78e-05 | 150 | 117 | 5 | c2c51a3230c978e2fdb1b3ae14193d4014431b25 | |
| ToppCell | Control-Neu_1|Control / 5 Neutrophil clusters in COVID-19 patients | 5.35e-05 | 28 | 117 | 3 | eb8d8303c1a8f8f8cf9f8c2180406c06624690af | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.89e-05 | 162 | 117 | 5 | 2f19539c455d1e5d514725845234c7547020e6ad | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 7.30e-05 | 164 | 117 | 5 | d6806deabf5f5c355934387be2baae125ac33fb8 | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.89e-05 | 171 | 117 | 5 | 8772d6349db24de47f089df2032a80345db7177f | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.13e-05 | 172 | 117 | 5 | 7295bf3ae21a61dd6bcfa0dfb7a37d0f3e8f94ab | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.64e-05 | 174 | 117 | 5 | ccc79febfcf588d8294ffc712338be96de8a5033 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.64e-05 | 174 | 117 | 5 | 6688424fc4e40c3c4a89669a2bc79369a726f1e6 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 176 | 117 | 5 | 33323c97afe509147956b8df9f92ca6b0537e604 | |
| ToppCell | COVID-19-lung-MAST|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.02e-04 | 176 | 117 | 5 | 473c45a381ca109207d66ed1635668b391ea0e1f | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_2|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.02e-04 | 176 | 117 | 5 | 4bba41ebf9dd187c8705a6997ed039878de62b4e | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 1.05e-04 | 177 | 117 | 5 | 52c2ba74a8605260a2623e7d151286e504ac4d19 | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 177 | 117 | 5 | 3cb96d7d56c9ff90f1f8a6caaf49e580e2524c7d | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 178 | 117 | 5 | 8c5e9fab7b55a654ccaabf2c4d02397399d94616 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.10e-04 | 179 | 117 | 5 | 55fde77dae7f9e7f3431c3185d14212a25af83df | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.10e-04 | 179 | 117 | 5 | b7a2429d07d7146b32b3552a5f2a2542105a71e0 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-Macrophages|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.19e-04 | 182 | 117 | 5 | ea39b1b5db185b0cb11dfa2e01f3f972effbd770 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.22e-04 | 183 | 117 | 5 | 103c4c4595d8daa677679fd2fa1e99cd398e56dd | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-GHRL+_neuroendocrine|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.22e-04 | 183 | 117 | 5 | 8820cfed27b292bc0bc9cde4005219ed41900552 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-Cd4_positive_Macrophages|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 183 | 117 | 5 | 92ef926e6c1de8477fa4f35d1dae85482d8009de | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 183 | 117 | 5 | 24db9cc717e651586317c6a8e03a3401651273c1 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 183 | 117 | 5 | 107cc756c45d6e92181659868d91188814dae66d | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.25e-04 | 184 | 117 | 5 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | COPD-Myeloid-Macrophage_Alveolar|World / Disease state, Lineage and Cell class | 1.25e-04 | 184 | 117 | 5 | 7fd0b227c3750ffb80e41e92c60fcce46656be14 | |
| ToppCell | BAL-Severe-Myeloid-Macrophage|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.29e-04 | 185 | 117 | 5 | ae966929fb5bbb08ffcbac76cb21941638727f55 | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.29e-04 | 185 | 117 | 5 | 3beebaa92275086b1fae5f8c0c3d54016c5ba2aa | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.29e-04 | 185 | 117 | 5 | ceff11cfa679147ccfd0a0f8079e697a6bea34d9 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 185 | 117 | 5 | afbb88325e4a81c15ac1d0a004e3e1f4ba2ee87b | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 185 | 117 | 5 | 775b72319ef6acffd2c9a74293b9c1bccea33f42 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 1.29e-04 | 185 | 117 | 5 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | BAL-Severe-Myeloid-Macrophage|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.29e-04 | 185 | 117 | 5 | 9aea5ed8f9cee5ee933891203aac7adb85d68201 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 185 | 117 | 5 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.29e-04 | 185 | 117 | 5 | 42939b294ea3e871274d8b73124c850dc1904fd2 | |
| ToppCell | Severe_COVID-19-Myeloid-transitional_Macro|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.29e-04 | 185 | 117 | 5 | f7ef0d7740b4cfedc38846e802898c402dc411fd | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.29e-04 | 185 | 117 | 5 | ed7b26bdebfd0df2b4f5020a855a052d94ae7219 | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.29e-04 | 185 | 117 | 5 | 7a3612520ae4f0cd61480eadba31eecce001419d | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 186 | 117 | 5 | f1aa0c58336d23bcbe52a59e7af954d20085bdb6 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 186 | 117 | 5 | 8f77e552e613b6e124443c7f6ef5c1316a5ff8db | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 1.32e-04 | 186 | 117 | 5 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 187 | 117 | 5 | f0c6e53035b00772377c4d5f761b4d11026b911a | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 187 | 117 | 5 | 028e7d6e1211e123879d2f353dc32fae1185dd8e | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 187 | 117 | 5 | f20e7a1751694390f535ffb27b97e887220f8695 | |
| ToppCell | droplet-Marrow-nan-21m-Myeloid-Cd4_positive_Macrophages|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 188 | 117 | 5 | f94dc08948a823f47882aa0714b9a60de4ff85d5 | |
| ToppCell | droplet-Marrow-nan-21m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 188 | 117 | 5 | 7c67330c36696a7772364af67c6df4e6406fa742 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.42e-04 | 189 | 117 | 5 | b2542b6fcf7bc10d29158d42b03182a939ff135a | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.42e-04 | 189 | 117 | 5 | dc5164591dea45b420798b94dda211be03daa70c | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-04 | 189 | 117 | 5 | f57200c93d39c9bce1adba0a6a1c178c028dd86b | |
| ToppCell | IPF-Myeloid-Macrophage_Alveolar|IPF / Disease state, Lineage and Cell class | 1.46e-04 | 190 | 117 | 5 | e539ebc0f4c5ee5dba86c614387be7d91338ad47 | |
| ToppCell | TCGA-Kidney-Primary_Tumor|TCGA-Kidney / Sample_Type by Project: Shred V9 | 1.46e-04 | 190 | 117 | 5 | 773c4575d22483d89a54c8db0e09905deed0d088 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma|TCGA-Kidney / Sample_Type by Project: Shred V9 | 1.46e-04 | 190 | 117 | 5 | e3696e7542424c03d0a41136b10729a3dd09549a | |
| ToppCell | COPD-Myeloid-Macrophage_Alveolar|COPD / Disease state, Lineage and Cell class | 1.46e-04 | 190 | 117 | 5 | 006e31606d637033bc81333816ee332773d36b08 | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.46e-04 | 190 | 117 | 5 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.46e-04 | 190 | 117 | 5 | 1196b8ea2c44c7c80f5ee589dd517e6a413f2077 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.46e-04 | 190 | 117 | 5 | da58227565ad6a690828dd8554dd3670222f8582 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 190 | 117 | 5 | c03c735a0ed850bf460a1847f5e2dd61753e577d | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM3|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.49e-04 | 191 | 117 | 5 | 2b10a73c5d80e83d67a7121fb004a1aa86a537ef | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.49e-04 | 191 | 117 | 5 | 02e1ae144da7274171e055356d10e8d175c5347f | |
| ToppCell | Severe_COVID-19-Myeloid-TRAM3|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.49e-04 | 191 | 117 | 5 | 05867b96199a46a415848409130697c810d18937 | |
| ToppCell | BAL-Severe-Myeloid-TRAM|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.49e-04 | 191 | 117 | 5 | 4c4f50a502e3f6768a89df686fa2830b83b8b33f | |
| ToppCell | COVID-19-lung-Macrophage_PPARGhi_CD5Lhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.53e-04 | 192 | 117 | 5 | bcfb9c005166bc0b4f8ee2dfc0c1540e8bf0e1ff | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.53e-04 | 192 | 117 | 5 | 34505a13b8a47c9286c560122fa7861b9c331a08 | |
| ToppCell | COVID-19-Myeloid-TRAM1|COVID-19 / Condition, Lineage and Cell class | 1.53e-04 | 192 | 117 | 5 | 52b8578699325b0d35a2d3ba36772096130ccc0c | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.53e-04 | 192 | 117 | 5 | 57c1410ebf90c230993e065eb78385daa3360960 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 193 | 117 | 5 | 06b65110db974f4ef90d3511ff34428976a52c9c | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D122|Adult / Lineage, Cell type, age group and donor | 1.57e-04 | 193 | 117 | 5 | cc1b6d3bf56e4a88f6fe23dd036a83cf5538c958 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.57e-04 | 193 | 117 | 5 | 294cb5b580bb83fe0eb04f112d5507aac35d4d44 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 193 | 117 | 5 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | COVID-19-Myeloid-TRAM1|Myeloid / Condition, Lineage and Cell class | 1.57e-04 | 193 | 117 | 5 | 6e6a7f4e50c8ae70bc187b9ce77140a7049dd288 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 193 | 117 | 5 | a4f91bca5eaa985982d33a528f7566ffde154d47 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.57e-04 | 193 | 117 | 5 | 50c2832de75b6469f649355c6b9a75e910d32db3 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.57e-04 | 193 | 117 | 5 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.57e-04 | 193 | 117 | 5 | 222829c30ebe47f0ed1e035897e3cd4be10b2a11 | |
| Drug | methyl 9-octadecenoate | 1.16e-07 | 112 | 117 | 8 | CID000008202 | |
| Drug | plakin | 4.12e-06 | 82 | 117 | 6 | CID000018752 | |
| Drug | Decamethonium bromide [541-22-0]; Down 200; 9.6uM; HL60; HT_HG-U133A | 8.94e-06 | 199 | 117 | 8 | 2933_DN | |
| Drug | chlorphentermine | 9.07e-06 | 26 | 117 | 4 | CID000010007 | |
| Drug | benzaldehyde oxime | 1.55e-05 | 10 | 117 | 3 | CID000012143 | |
| Drug | 20,25-diazacholesterol | 2.12e-05 | 11 | 117 | 3 | CID000009402 | |
| Drug | cupreidine | 2.62e-05 | 2 | 117 | 2 | CID000051196 | |
| Drug | ADR-033 | 2.62e-05 | 2 | 117 | 2 | CID000005586 | |
| Drug | 3-methoxyphenethylamine | 2.62e-05 | 2 | 117 | 2 | CID000074866 | |
| Drug | lead azide | 2.62e-05 | 2 | 117 | 2 | CID000061600 | |
| Drug | S 105 | 2.81e-05 | 12 | 117 | 3 | CID000031154 | |
| Drug | M-NR | 3.07e-05 | 35 | 117 | 4 | CID003000480 | |
| Drug | AC1L1JL9 | 3.64e-05 | 13 | 117 | 3 | CID000005091 | |
| Drug | testosterone enanthate | PRUNE2 SART3 CHD4 ADAMTSL3 FANCC CUL5 TCF25 MACF1 IFI44L HADHA PROS1 FAM149A | 4.14e-05 | 575 | 117 | 12 | ctd:C004648 |
| Drug | Acetohexamide [968-81-0]; Up 200; 12.4uM; PC3; HT_HG-U133A | 6.17e-05 | 192 | 117 | 7 | 1829_UP | |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A | 6.80e-05 | 195 | 117 | 7 | 3721_DN | |
| Drug | Liothyronine [6893-02-3]; Down 200; 6.2uM; MCF7; HT_HG-U133A | 7.02e-05 | 196 | 117 | 7 | 3324_DN | |
| Drug | Neomycin sulfate [1405-10-3]; Up 200; 4.2uM; MCF7; HT_HG-U133A | 7.25e-05 | 197 | 117 | 7 | 2229_UP | |
| Drug | Nifenazone [2139-47-1]; Down 200; 13uM; MCF7; HT_HG-U133A | 7.49e-05 | 198 | 117 | 7 | 6016_DN | |
| Drug | Azlocillin sodium salt [37091-65-9]; Down 200; 8.2uM; PC3; HT_HG-U133A | 7.73e-05 | 199 | 117 | 7 | 5788_DN | |
| Drug | 2,4,6-trimethylbenzaldoxime | 7.83e-05 | 3 | 117 | 2 | CID000283782 | |
| Drug | O-demethyl encainide | 7.83e-05 | 3 | 117 | 2 | CID000054736 | |
| Drug | Mfpa | 7.83e-05 | 3 | 117 | 2 | CID003035615 | |
| Drug | B234 | 7.83e-05 | 3 | 117 | 2 | CID006435969 | |
| Drug | chlorpromazine N-oxide | 7.83e-05 | 3 | 117 | 2 | CID000443037 | |
| Drug | Wang resin | 7.83e-05 | 3 | 117 | 2 | CID000070043 | |
| Drug | ddTTP | 8.22e-05 | 86 | 117 | 5 | CID000065051 | |
| Drug | AC1L1B3Z | 8.39e-05 | 45 | 117 | 4 | CID000001273 | |
| Drug | AC1NV8O5 | 8.39e-05 | 45 | 117 | 4 | CID005473386 | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 1.09e-05 | 36 | 113 | 4 | DOID:11723 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | CYP2D6 FRMPD1 OBSCN CUL5 ALKBH8 NF1 WDCP NISCH MROH7 MACF1 TIMELESS MME DMD MED12 RUSF1 | 1.53e-05 | 1074 | 113 | 15 | C0006142 |
| Disease | Duchenne muscular dystrophy (is_implicated_in) | 4.35e-05 | 3 | 113 | 2 | DOID:11723 (is_implicated_in) | |
| Disease | muscular dystrophy (implicated_via_orthology) | 6.92e-05 | 21 | 113 | 3 | DOID:9884 (implicated_via_orthology) | |
| Disease | Hereditary elliptocytosis | 8.68e-05 | 4 | 113 | 2 | cv:C0013902 | |
| Disease | solanidine measurement | 8.68e-05 | 4 | 113 | 2 | EFO_0800966 | |
| Disease | testosterone measurement | CYP2D7 EML4 RMI2 DAG1 UNC13D URB1 NF1 ZNF655 NISCH MACF1 MME AKR1B1 UTRN MED12 MYO16 | 1.07e-04 | 1275 | 113 | 15 | EFO_0004908 |
| Disease | hereditary spherocytosis (is_implicated_in) | 1.44e-04 | 5 | 113 | 2 | DOID:12971 (is_implicated_in) | |
| Disease | Duchenne muscular dystrophy (is_marker_for) | 1.44e-04 | 5 | 113 | 2 | DOID:11723 (is_marker_for) | |
| Disease | Hereditary spherocytosis | 1.44e-04 | 5 | 113 | 2 | cv:C0037889 | |
| Disease | Anemia, hereditary spherocytic hemolytic | 1.44e-04 | 5 | 113 | 2 | C0221409 | |
| Disease | reticulocyte measurement | ABCA1 ARHGEF28 SPTA1 SPTB RMI2 FKBP9 ITGAX CUL5 CCM2 NISCH TCF25 AKR1B1 MED12 | 2.00e-04 | 1053 | 113 | 13 | EFO_0010700 |
| Disease | 3-hydroxyisobutyrate measurement | 2.16e-04 | 6 | 113 | 2 | EFO_0010983 | |
| Disease | Elliptocytosis, Hereditary | 2.16e-04 | 6 | 113 | 2 | C0013902 | |
| Disease | Colorectal Carcinoma | 3.75e-04 | 702 | 113 | 10 | C0009402 | |
| Disease | Hereditary spherocytosis | 4.01e-04 | 8 | 113 | 2 | C0037889 | |
| Disease | reticulocyte count | ABCA1 ARHGEF28 SPTA1 SPTB RMI2 FKBP9 ITGAX CCM2 NISCH TCF25 AKR1B1 MED12 | 6.77e-04 | 1045 | 113 | 12 | EFO_0007986 |
| Disease | nervous system disease (implicated_via_orthology) | 9.36e-04 | 12 | 113 | 2 | DOID:863 (implicated_via_orthology) | |
| Disease | Prostatic Neoplasms | 2.59e-03 | 616 | 113 | 8 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.59e-03 | 616 | 113 | 8 | C0376358 | |
| Disease | Alzheimer disease | 2.69e-03 | 485 | 113 | 7 | MONDO_0004975 | |
| Disease | PR interval | 3.01e-03 | 495 | 113 | 7 | EFO_0004462 | |
| Disease | otitis media (implicated_via_orthology) | 3.19e-03 | 22 | 113 | 2 | DOID:10754 (implicated_via_orthology) | |
| Disease | pars opercularis volume measurement | 3.19e-03 | 22 | 113 | 2 | EFO_0010319 | |
| Disease | unipolar depression, response to selective serotonin reuptake inhibitor | 3.80e-03 | 24 | 113 | 2 | EFO_0003761, EFO_0005658 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WLTLDSQVIMADSEI | 96 | Q9UPW8 | |
| DSDNLQHEELLMKLW | 121 | Q8IZ81 | |
| ISADSEIEENMVEWL | 466 | Q93034 | |
| MLLESVDWTEDTDNQ | 151 | Q96BT7 | |
| HNVLFDMLTVEEHIW | 981 | O95477 | |
| VLDHWSIMTSEEEVA | 151 | Q01954 | |
| WDRMISDISSDIEAL | 421 | Q9BSQ5 | |
| NVLTEWLAATDMELT | 1581 | P11532 | |
| PEMQVSDSDHDWVIL | 636 | Q6Q4G3 | |
| SDSDHDWVILNLNMT | 641 | Q6Q4G3 | |
| HIDWDSVLIDMDNVI | 581 | Q8N608 | |
| TNILDTWAAMEELVD | 136 | P15121 | |
| DWLVEVQVSFEMTHE | 1166 | Q8WWL7 | |
| EAMTAVDTEAVWLLQ | 336 | P54802 | |
| HTVPLEENLESWSEM | 366 | Q68CQ1 | |
| VIHSADITFQMLEDW | 336 | Q33E94 | |
| ELNQEAVWMDVEVSH | 976 | P20702 | |
| WNEEALLTTMDIIHD | 436 | Q14739 | |
| IMEDVVDSSLWSDLS | 806 | Q8N1W1 | |
| SLQWMKDNDIHDILD | 1356 | Q9P2P5 | |
| WILTDHILETKEASM | 646 | Q7L576 | |
| WLSLSMDTVEDTLEA | 91 | Q8N239 | |
| EVFDHVWTNMVELLE | 456 | A5PLN7 | |
| LLDEESQMIWSVESN | 851 | Q9Y6X6 | |
| LEAAIHQVSDWMEQE | 846 | Q5JYT7 | |
| GEDEVELMNWLNEVH | 5616 | Q03001 | |
| VEDAQMHTVTIWLTV | 61 | Q9BYM8 | |
| VWVTHEEMETLETST | 911 | O75335 | |
| MEVTTRLTWNDENHL | 1 | Q53G44 | |
| DWENQLEASMHSVLS | 41 | Q14118 | |
| QSMDESLHLGWELEQ | 421 | Q3V6T2 | |
| SSMEDHLEILEWTLR | 356 | P49005 | |
| EWHSILVEEMDASIR | 3851 | Q9NYQ8 | |
| MAPSEEDHSILWDAI | 141 | P08833 | |
| AATLLDEDIWEEIQM | 721 | Q2TBE0 | |
| FIQTLDDLTWMDAET | 451 | P08473 | |
| MNLESSLEEDHRIFW | 361 | Q9HD23 | |
| LEHDMEEINARWNTL | 1441 | O94854 | |
| QHALEELMSWLTHTE | 2356 | O94854 | |
| ELMSWLTHTEELLDA | 2361 | O94854 | |
| HELSQWMDVLEIDRV | 301 | Q99583 | |
| DGMLDRHEFLTWVLE | 246 | Q93074 | |
| LEEHMQWKNSTLLDT | 166 | A0A087WXM9 | |
| SEEEEEWMAQILQIL | 996 | Q92616 | |
| VLMWNHDDSLLLELD | 186 | P98088 | |
| QEVSDLVEMIWAEAL | 261 | Q9UKK3 | |
| LAWLDSVFDLVMVAE | 291 | Q96RP7 | |
| MEEADKLLWSVQVDH | 291 | Q969R8 | |
| ALEELMSWLTHTEEL | 6231 | Q9UPN3 | |
| MSWLTHTEELLDAQR | 6236 | Q9UPN3 | |
| DTVHMLLEWLSEAEQ | 6776 | Q9UPN3 | |
| DALWHEEAVLTTMDI | 236 | O76062 | |
| LSHEDEEVEWSLNGM | 2581 | Q5VST9 | |
| VLHFDVLLMDIWNSE | 131 | O95302 | |
| LPENITADTLEHWME | 1691 | Q9BXP8 | |
| HQETQAAEIWDMSDD | 686 | O95352 | |
| ELLTVFMDWISDHHL | 356 | Q96M89 | |
| ELDNLVMVLSDHVIW | 1026 | Q96BY6 | |
| STLEEMIQQHQEWLE | 326 | O14981 | |
| LDELLTEHRMTWDPA | 251 | P10635 | |
| MESLLELQDILETSW | 1426 | Q5SYB0 | |
| WDVITLMAHTAEITH | 506 | Q00597 | |
| MSRLLHAEEWAEVKE | 1 | Q92858 | |
| KELHSEFSEVMNEIW | 66 | P40939 | |
| LDTAETLDMASHTWL | 46 | Q8IXV7 | |
| AVEIPSEWHIELMLD | 746 | Q9H583 | |
| EDMILDCELNWHQAS | 176 | Q8IYV9 | |
| LCVVDDSNEHMLSVW | 376 | Q32P44 | |
| CIIDDSNEHMLTVWD | 381 | Q9HC35 | |
| DHNMDNTSTVLREWL | 91 | Q8NBJ5 | |
| SAQLLEDWGMEDIDH | 151 | Q14839 | |
| EWLHDEISMAQDGLD | 151 | Q15020 | |
| HEEVTQLMLWVLENL | 1006 | Q9NZJ4 | |
| ALLTDWSDDTMKELH | 51 | Q1ZYL8 | |
| IWINEEDHTRVISME | 261 | P17540 | |
| LEQTDHWGSTEMELA | 441 | Q8NAN2 | |
| SWVVVKETHEVLDML | 416 | Q96GQ5 | |
| DMHNFTNEILTWDLV | 331 | O95197 | |
| VLELVDSMANWVHHT | 531 | Q9H0K4 | |
| ATDELSHAWEDVKAM | 256 | P84550 | |
| LEDMIIDSLQWDDHR | 2331 | P46939 | |
| DFWILAENILSIDEM | 106 | A5PLK6 | |
| ILASSKEMWHSLQED | 116 | Q5JUK2 | |
| SDNPIHESMWELEVE | 126 | Q96E14 | |
| HESMWELEVEDLHRN | 131 | Q96E14 | |
| ITLHEMAETDEGWLD | 126 | Q96DX4 | |
| TKEWSEMINTHSAEE | 1021 | Q15147 | |
| AVTLQAVTHDNEWEM | 2711 | Q8WUY3 | |
| VTSMDHQERLDQWLS | 126 | Q9BRC7 | |
| LADENFLMVTQLHWE | 416 | Q8IZX4 | |
| NFLMVTQLHWEDDII | 401 | P21675 | |
| WISLEEHQDALELIM | 91 | Q9BRV8 | |
| EVHWANLTVSECQEM | 661 | Q2Y0W8 | |
| MDLEAVHDVLDLYLW | 626 | Q8IYB8 | |
| DPFESHTDEMLWQVL | 1216 | Q96J65 | |
| GLWNMVSVEELEHSI | 381 | P07225 | |
| KELELWLEHLENTME | 676 | O60287 | |
| WLEHLENTMEEDKET | 681 | O60287 | |
| MEDSLLQIQDSWATH | 316 | Q9C0B6 | |
| MHVTWSDIAGLDDVI | 86 | Q8NBU5 | |
| LDELLTEHRMTWDPA | 251 | A0A087X1C5 | |
| DMELVDPDLHNSLVW | 521 | Q9HAU4 | |
| EEQWSLHVLEIVSLM | 211 | Q9UNS1 | |
| VQELHSELMWKDFID | 571 | Q9C0D3 | |
| MLDDLYEDIHWLILV | 531 | Q9C0E2 | |
| SLVMSQRWDSNIEEH | 466 | O60673 | |
| AEVENEELRHLMWSS | 1151 | Q9Y2I1 | |
| IDLSDTDSLQEWINM | 826 | P21359 | |
| TPTLEQHLMWDDIAI | 2066 | P21359 | |
| IDWMDEIKAHLLSAE | 541 | P11277 | |
| IQEMKEDLVSSWEHI | 341 | P02549 | |
| TPQKEWLHMDTVELE | 321 | Q9BWH6 | |
| RWDMADNEQVLTTEH | 121 | P13994 | |
| LETIFNAVMLWEDET | 141 | Q8IYL9 | |
| THEITQLESWEEPFM | 61 | Q6PK81 | |
| MEELTIWEQHTATLS | 1 | O95049 | |
| ESLMDLSHLNKWESI | 191 | Q8N720 | |
| HMEAVSSVLWSDAEE | 256 | Q9GZL7 | |
| HSSIMWINDLENDDL | 441 | Q9NYU1 | |
| NHHLMLEASEWATIE | 381 | O96006 | |
| IEMLHDSHWILLSAD | 641 | Q9H6R7 | |
| HLDMWDLDTVESVRQ | 201 | Q70J99 | |
| KEPATMSWLEENVHE | 511 | Q9BQ70 | |
| MSWLEENVHEVLQAV | 516 | Q9BQ70 | |
| SKASWETVHMILQEL | 136 | Q5QJ74 | |
| TITDVLELHDWMCTH | 196 | Q9UBP6 | |
| VEESMHGEILQVEEW | 446 | P82987 |